
Toxicities related to Teliso-V are manageable for patients with c-Met overexpressing non-small cell lung cancer, according to Jonathan Goldman, MD.
Jonathan Goldman, MD is a professor of medicine at the David Geffen School of Medicine at University of California, Los Angeles. He specializes in lung cancer, hematology, solid tumors, and early drug development.

Published: June 3rd 2025 | Updated: